This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Fraunhofer-Gesellschaft Zur Foerderung Der Angewandten Forschung E.v.. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Kerstin Boll: Innovator in Cancer Treatment
Introduction
Kerstin Boll is a prominent inventor based in Leipzig, Germany. She has made significant contributions to the field of cancer treatment, particularly through her innovative work with miRNA compounds. Her research focuses on developing new pharmaceutical compositions that can aid in the fight against prostate carcinoma.
Latest Patents
Kerstin Boll holds 1 patent for her invention titled "miRNA compounds for treatment of prostate carcinoma." This invention relates to new pharmaceutical compositions comprising miRNAs miR-130a, miR-203, and miR-205, which are utilized for the treatment of cancer, specifically prostate cancer. Her work represents a promising advancement in cancer therapeutics.
Career Highlights
Kerstin is affiliated with the Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung E.V., a leading research organization in Germany. Her role at this esteemed institution allows her to collaborate with other experts in the field and contribute to groundbreaking research.
Collaborations
Some of her notable coworkers include Friedemann Horn and Jörg Hackermüller. Their collaborative efforts enhance the research environment and foster innovation in cancer treatment.
Conclusion
Kerstin Boll's work exemplifies the vital role of inventors in advancing medical science. Her contributions to the treatment of prostate cancer through innovative miRNA compounds highlight the importance of research and collaboration in the fight against cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile